Bookrunners Stifel, Cowen and Co. and Lazard Capital Markets assist
By Devika Patel
Knoxville, Tenn., Sept. 25 - TherapeuticsMD Inc. said it priced a $33 million public sale of stock.
The company will sell 13.75 million common shares at $2.40 per share. The price per share is a 14.89% discount to the Sept. 24 closing share price of $2.82.
Stifel, Cowen and Co. and Lazard Capital Markets are the joint bookrunning managers.
Settlement is expected Sept. 30.
The pharmaceutical company is based in Boca Raton, Fla.
| Issuer: | TherapeuticsMD Inc.
|
| Issue: | Common stock
|
| Amount: | $33 million
|
| Shares: | 13.75 million
|
| Price: | $2.40
|
| Warrants: | No
|
| Bookrunners: | Stifel, Cowen and Co. and Lazard Capital Markets
|
| Pricing date: | Sept. 25
|
| Settlement date: | Sept. 30
|
| Stock symbol: | OTCBB: TXMD
|
| Stock price: | $2.82 at close Sept. 24
|
| Market capitalization: | $367.39 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
